Category: Life Sciences
Global Life Sciences
-
Deep Brain Stimulation Devices
... 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Dual-Channel Devices, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$1.7 Billion by the ... Read More
-
Body Contouring Treatments Market by Product (System (CT, MRI, Angiography, Mammo), Consumable, Accessories), Type (Single & Dual-head, Syringeless), Application (General Imaging, Interventional), and End user - Global Forecast to 2029
... procedures, coupled with personalized and flexible financing plans has increased the demand for these products. Growing interest in anti-aging procedures are more prevalent in aging population. Body contouring procedures helps to reshape and improvesconfidence. Moreover,increased ... Read More
-
Hospital Acquired Infection Control
... 2030, growing at a CAGR of 2.2% over the analysis period 2024-2030. Protective Barrier, one of the segments analyzed in the report, is expected to record a 2.0% CAGR and reach US$11.1 Billion by the ... Read More
-
Missiles
... 4.7% over the analysis period 2024-2030. Surface-to-Surface Missiles, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$63.6 Billion by the end of the analysis period. Growth ... Read More
-
Blood Banking and Blood Products
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Blood Components & Plasma Products, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and ... Read More
-
Adhesion Barriers
... CAGR of 6.6% over the analysis period 2024-2030. Synthetic Adhesion Barriers, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$825.4 Million by the end of the ... Read More
-
Agrigenomics
... 8.1% over the analysis period 2024-2030. Illumina Hi Seq Family, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$3.5 Billion by the end of the analysis ... Read More
-
Anatomic Pathology
... CAGR of 5.8% over the analysis period 2024-2030. Anatomic Pathology Services, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$36.4 Billion by the end of the ... Read More
-
Antioxidants
... 5.7% over the analysis period 2024-2030. Synthetic Antioxidants, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.9 Billion by the end of the analysis period. Growth ... Read More
-
Assisted Reproductive Technology
... at a CAGR of 4.9% over the analysis period 2024-2030. In-Vitro Fertilization (IVF), one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$22.0 Billion by the end ... Read More
-
Automotive Lighting
... CAGR of 6.0% over the analysis period 2024-2030. Halogen Lighting, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$28.2 Billion by the end of the analysis ... Read More
-
Teleradiology
... 17.2% over the analysis period 2024-2030. X-ray, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$5.2 Billion by the end of the analysis period. Growth in ... Read More
-
Terahertz Technology
... CAGR of 28.8% over the analysis period 2024-2030. Terahertz Source Technology, one of the segments analyzed in the report, is expected to record a 29.1% CAGR and reach US$1.8 Billion by the end of the ... Read More
-
Ventilator Test Systems
... at a CAGR of 3.6% over the analysis period 2024-2030. Critical Care Ventilators, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$111.1 Million by the end ... Read More
-
Bovine-Based Collagen for Biomedical Applications
... Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Bone Graft Substitutes Application, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach ... Read More
-
Neurology Devices
... CAGR of 5.9% over the analysis period 2024-2030. Cerebrospinal Fluid Management, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$7.1 Billion by the end of the ... Read More
-
Biological Drugs
... CAGR of 9.1% over the analysis period 2024-2030. Therapeutic Protein, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$289.1 Billion by the end of the analysis ... Read More
-
Biologics
... 8.2% over the analysis period 2024-2030. Recombinant Therapeutic Proteins, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$271.3 Billion by the end of the analysis period. ... Read More
-
Biopharmaceutical Logistics
... CAGR of 4.8% over the analysis period 2024-2030. Cold Chain Logistics, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$37.9 Billion by the end of the ... Read More
-
Bio-MEMS
... 16.7% over the analysis period 2024-2030. Microfluidic Chips, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$27.4 Billion by the end of the analysis period. Growth ... Read More
-
Blood Transfusion Diagnostics
... at a CAGR of 4.7% over the analysis period 2024-2030. Blood Transfusion Diagnostic Instruments, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.7 Billion by the ... Read More
-
Digital Radiography
... CAGR of 5.9% over the analysis period 2024-2030. Computed Radiography (CR), one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$17.0 Billion by the end of the ... Read More
-
Lung Cancer Therapeutics
... at a CAGR of 10.8% over the analysis period 2024-2030. Non-Small-Cell Lung Cancer (NSCLC) Therapeutics, one of the segments analyzed in the report, is expected to record a 11.9% CAGR and reach US$82.3 Billion by ... Read More
-
Medical Waste Management
... at a CAGR of 4.2% over the analysis period 2024-2030. Collection, Transportation & Storage Services, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$10.4 Billion by ... Read More
-
Cardiac Biomarkers
... CAGR of 7.3% over the analysis period 2024-2030. Troponins (T & I), one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$11.2 Billion by the end of ... Read More
Research Assistance
